• Collaborating Against Cancer

  • Jun 4 2021
  • Duración: 29 m
  • Podcast

Collaborating Against Cancer

  • Resumen

  • In this episode, we hear from Dr Scott DeWire, Head of US Business Development at Boehringer Ingelheim (BI) and Dr Andrew Fadden, Head of Corporate Development at Enara Bio about the power of research partnerships in progressing cancer innovation and drug development. Their discussion proves that embracing collaboration is essential in delivering ground-breaking treatments to patients, faster. What do pharmaceutical partnerships entail? What can we gain from collaborating with partners? Do we share the same goals? Listen to this episode to find out more!
    Más Menos

Lo que los oyentes dicen sobre Collaborating Against Cancer

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.